Myriaporone 3/4 structure–activity relationship studies define a pharmacophore targeting eukaryotic protein synthesis

Por Hines, John, Roy, Myriam, Cheng, Hua, Agapakis, Christina M., Taylor, Richard, Crews, Craig M.
Publicado em 2006

Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications

Por Correard, Florian, Maximova, Ksenia, Estève, Marie-Anne, Villard, Claude, Roy, Myriam, Al-Kattan, Ahmed, Sentis, Marc, Gingras, Marc, Kabashin, Andrei V, Braguer, Diane
Publicado no Int J Nanomedicine (2014)